In a key advance for regenerative medicine and gut health, scientists from Duke-NUS Medical School and Nanyang Technological ...

Explore the future of cancer treatment with the "Global KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025" report. Discover insights on therapies, ...

Neil Gallagher M.D., Ph.D., former AbbVie Chief Medical Officer and President of R&D at Syndax, brings considerable experience in oncology drug ...

Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in ...

Ahead of the 10-year anniversary of Tagrisso’s initial FDA approval this fall, AstraZeneca has debuted the first ...

A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...

Bonilla, MD, MSEd, discusses the significant advancements and ongoing efforts in integrating artificial intelligence into oncology.

Dispatch seeks to address two main challenges of immunotherapies in solid tumors: the lack of a target and the ...

During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

Suspects broke in to the "Real Housewives of Beverly Hills" star's home, but fled after less than a minute, according to her ...

Kiran Musunuru, a University of Pennsylvania cardiologist and leading gene-editing researcher, thinks it’s possible. Musunuru cofounded Verve Therapeutics, a company developing a therapy that uses ...

The abstracts accepted for mini oral presentations include updated efficacy and safety data from the Phase 2b REZILIENT1 ...